摘要
目的 观察脑脉通对脑动脉硬化症ET、MDA、CRP的影响。方法 用西比灵、舒降之、肠溶阿司匹林作为对照,记录服药前后脑血流图,脑血管多普勒超声血流图、血ET、MDA、CRP,血粘和血脂的情况及头晕、头痛、健忘、失眠、血管杂音等症状和体征。结果 经脑脉通治疗后,患者ET、MDA、CRP都明显降低,ET(pg/mL)由67.53±15.47改善为39.76±9.24,MDA(mol/mL)由8.95±1.79改善为6.78±1.45,CRP(mg/L)由12.43±6.56改善为6.42±2.68,脑动脉硬化症总有效率为92%,与对照组相比没有明显差异(P>0.05)。结论 脑脉通治疗脑动脉硬化症疗效明显,能明显降低ET、MDA、CRP,且没有任何毒副作用。
Objective To observe the influences of ET, MDA, CRP on the Naomaitong in patients with brain artoriosclerosis. Methods 50 patients with brain arteriosclerosis were treated by Naomaitong and ET, MDA, CRP, symptoms, signs, blood viscosity and blood fat were recorded. Results Obvious drop of ET, MDA, CRP. The improving of ET (pg/mL) from 67.53±15.47 to 39.76±9.24, MDA (祄ol/mL) from8.95±1.79 to 6.78±1.45, CRP (mg/L) from 12.43±6.56 to 6.42±2.68, the total efficacy of Naomaitong amounted to 92%, clinical symptoms and signs disappearing or improving. There was no significant difference between these two groups (P>0.05). Conclusion Naomaitong is useful to the treatment of brain arteriosclerosis and obvious drop of blood ET, MDA, CRP, without any side effect.
出处
《中国中医药信息杂志》
CAS
CSCD
2004年第6期487-488,共2页
Chinese Journal of Information on Traditional Chinese Medicine
